By Associate Professor Suzanne Jean Hodgkinson

Conference Papers

Diouf I; Malpas CB; Sharmin S; Skibina O; Buzzard K; Lechner-Scott J; Barnett M; Hodgkinson S; Slee M; Butler E; McCombe P; Walt AVD; Butzkueven H; Vucic S; Macdonell R; Shaw C; Kalincik T, 2021, '006 Comparison of multiple disease modifying therapies in multiple sclerosis with marginal structural models', in Oral abstracts, BMJ Publishing Group Ltd, pp. A3.1 - A3, presented at ANZAN Annual Scientific Meeting 2021 Abstracts, http://dx.doi.org/10.1136/bmjno-2021-anzan.6

Roos I; Malpas CB; Leray E; Buzzard K; Skibina O; Lechner-Scott J; McCombe P; Slee M; Butler E; Macdonell R; Walt AVD; Hodgkinson S; Barnett M; Vucic S; Vukusic S; Butzkueven H; Kalincik T, 2021, '008 Disease reactivation after cessation of disease-modifying therapy in relapsing-remitting multiple sclerosis', in Oral abstracts, BMJ Publishing Group Ltd, pp. A4.1 - A4, presented at ANZAN Annual Scientific Meeting 2021 Abstracts, http://dx.doi.org/10.1136/bmjno-2021-anzan.8

Butzkueven H; Spelman T; Kalincik T; Buzzard K; Walt AVD; Lechner-Scott J; Hodgkinson S; Butler E; Macdonell R; Slee M; Group MS; Marcel B, 2021, '010 Real-world experience with ocrelizumab in the MSBase registry – Australian RRMS cohort', in Oral abstracts, BMJ Publishing Group Ltd, pp. A4.3 - A5, presented at ANZAN Annual Scientific Meeting 2021 Abstracts, http://dx.doi.org/10.1136/bmjno-2021-anzan.10

Yeh W; Widyastuti P; Van der Walt A; Stankovich J; Gresle M; Havrdova E; Horakova D; Vodehnalova K; Ozakbas S; Eichau S; Duquette P; Kalincik T; Patti F; Boz C; Terzi M; Yamout B; Lechner-Scott J; Sola P; Skibina O; Barnett M; Onofrj M; Sa MJ; Mccombe P; Grammond P; Ampapa R; Grand'Maison F; Bergamaschi R; Spitaleri D; Van Pesch V; Cartechini E; Hodgkinson S; Soysal A; Saiz A; Uher T; Maimone D; Turkoglu R; Hupperts R; Amato MP; Granella F; Oreja-Guevara C; Altintas A; Macdonell R; Castillo-Trivino T; Butzkueven H; Alroughani R; Jokubaitis V, 2020, 'Pregnancy in a modern day multiple sclerosis cohort: predictors of relapse during pregnancy', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, ELECTR NETWORK, pp. 30 - 31, presented at 8th Joint ACTRIMS-ECTRIMS Meeting (MSVirtual), ELECTR NETWORK, 11 September 2020 - 13 September 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000596547100057&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Butzkueven H; Spelman T; Hodgkinson S; Kalincik T; Buzzard K; Skibina O; Eichau Madueno S; Izquierdo G; Van der Walt A; Grand-Maison F; Butler E; Prevost J; Mccombe P; Oh J; Macdonell R; Lechner-Scott J; Van Pesch V; Duquette P; Prat A; Girard M; Kermode A; Fabris J, 2020, 'Real-world experience with cladribine tablets in the msbase registry', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, ELECTR NETWORK, pp. 549 - 549, presented at 8th Joint ACTRIMS-ECTRIMS Meeting (MSVirtual), ELECTR NETWORK, 11 September 2020 - 13 September 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000596547101671&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

De Stefano N; Achiron A; Barkhof F; Chan A; Derfuss T; Hodgkinson S; Leocani L; Montalbant X; Pratt A; Schmierer K; Sellebjerg F; Vermersch P; Wiendl H; Keller B; Roy S, 2020, 'A 2-year Study to Evaluate the Onset of Action of Cladribine Tablets in Subjects with Highly Active Relapsing Multiple Sclerosis: Results from MAGNIFY- MS Baseline Analysis', in EUROPEAN JOURNAL OF NEUROLOGY, WILEY, ELECTR NETWORK, pp. 685 - 686, presented at 6th Congress of the European-Academy-of-Neurology (EAN), ELECTR NETWORK, 23 May 2020 - 26 May 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000534616801566&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Malpas CB; Roos I; Sharmin S; Butzkueven H; Kappos L; Patti F; Alroughani R; Horakova D; Havrdova EK; Izquierdo G; Eichau S; Hodgkinson S; Grammond P; Lechner-Scott J; Kalincik T, 2019, 'Disease reactivation following fingolimod cessation', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, SWEDEN, Stockholm, pp. 330 - 331, presented at 35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, SWEDEN, Stockholm, 11 September 2019 - 13 September 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000485303101223&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Butzkueven H; Spelman T; Patti F; Eichau S; Grand'Maison F; Kalincik T; Hodgkinson S; Skibina O; Butler E, 2019, 'Real-world experience with Cladribine in the MSBase Registry', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, SWEDEN, Stockholm, pp. 326 - 327, presented at 35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, SWEDEN, Stockholm, 11 September 2019 - 13 September 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000485303101217&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Butzkueven H; Spelman T; Patti F; Ozakbas S; Eichau S; Alroughani R; Terzi M; Boz C; Grand'Maison F; Grammond P; Kalincik T; Van Pesch V; Lechner-Scott J; Barnett M; Kuhle J; Hodgkinson S; Skibina O; Soysal A; Butler E; Slee M; Prevost J; Laureys G; Macdonell R; van Beek J; Craveiro L; Wormser D; Muros-Le Rouzic E, 2019, 'Real-world experience with Ocrelizumab in the MSBase Registry', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, SWEDEN, Stockholm, pp. 539 - 540, presented at 35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, SWEDEN, Stockholm, 11 September 2019 - 13 September 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000485303102197&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Hodgkinson S; Sharma M, 2019, 'Temporal profile of lymphocytes following treatment with cladribine tablets in patients switching from lymphocyte depleting or sequestering diseased modifying drugs (DMDs)', in NEUROLOGY, LIPPINCOTT WILLIAMS & WILKINS, PA, Philadelphia, presented at 71st Annual Meeting of the American-Academy-of-Neurology (AAN), PA, Philadelphia, 04 May 2019 - 10 May 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000475965903372&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Haartsen J; Spelman T; Baker J; Agland S; Lechner-Scott J; Burke T; Vucic S; Rath L; Skibina O; Toubia M; Slee M; Taylor B; Mac Gregor S; Oconnell AM; Barnett M; Baker S; Sharma M; Hodgkinson S; Walters S; Kermode A; Hayes W; Butler E; Sheuy N; Shaw C; Portley R; Hardy T; Tan IL; Butzkueven H, 2017, 'MS FIRST - utilising a longitudinal, prospective, comparative drug safety module for use in everyday MS clinical practice to evaluate and track incidence and characteristics of safety outcomes in MS patients on therapy over the long term', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, FRANCE, Paris, pp. 403 - 404, presented at 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), FRANCE, Paris, 25 October 2017 - 28 October 2017

Kister I; Spelman T; Patti F; Duquette P; Trojano M; Izquierdo G; Lugaresi A; Grammond P; Sola P; Ferraro D; Grand'Maison F; Alroughani R; Terzi M; Boz C; Hupperts R; Lechner-Scott J; Kapos L; Pucci E; Hodgkinson S; Solaro C; Butzkueven H, 2017, 'Predictors of relapses and disability progression after stopping disease-modifying therapies for multiple sclerosis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, FRANCE, Paris, pp. 356 - 357, presented at 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), FRANCE, Paris, 25 October 2017 - 28 October 2017

Jokubaitis VG; Havrdova E; Horakova D; Izquierdo G; Kalincik T; van der Walt A; Nguyen A-L; Terzi M; Alroughani R; Duquette P; Girard M; Prat A; Boz C; Sola P; Lugaresi A; Lechner-Scott J; Barnett M; Grand'Maison F; Grammond P; Ramo C; Turkoglu R; McCombe P; Hupperts R; Bolanos RF; Pucci E; Trojano M; Granella F; Spitaleri D; Van Pesch V; Soysal A; Oreja-Guevara C; Verheul F; Vucic S; Hodgkinson S; Slee M; Ampapa R; Prevost J; Menoyo JLS; Skibina O; Iuliano G; Solaro C; Olascoaga J; Shaw C; Madsen K; Naidoo K; Hyde R; Butzkueven H, 2017, 'Pregnancy incidence and therapy exposure in relapsing forms of MS: a 12-year retrospective multicentre analysis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, FRANCE, Paris, pp. 130 - 132, presented at 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), FRANCE, Paris, 25 October 2017 - 28 October 2017

Kalincik T; Jokubaitis V; Spelman T; Horakova D; Havrdova E; Trojano M; Lechner-Scott J; Lugaresi A; Prat A; Girard M; Duquette P; Grammond P; Solaro C; Grand'Maison F; Hupperts R; Prevost J; Sola P; Ferraro D; Terzi M; Butler E; Slee M; Kermode A; Fabis-Pedrini M; McCombe P; Barnett M; Shaw C; Hodgkinson S; Butzkueven H, 2017, 'Cladribine versus fingolimod, natalizumab and interferon beta for multiple sclerosis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, FRANCE, Paris, pp. 596 - 597, presented at 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), FRANCE, Paris, 25 October 2017 - 28 October 2017, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000413730203308&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kalincik T; Spelman T; Jokubaitis V; Horakova D; Havrdova E; Izquierdo G; Prat A; Girard M; Duquette P; Lugaresi A; Grammond P; Alroughani R; Lechner-Scott J; Prevost J; Terzi M; Grand'Maison F; Boz C; Trojano M; Van Wijmeersch B; Pucci E; Granella F; Turkoglu R; Sola P; Ferraro D; McCombe P; Solaro C; Van Pesch V; Ozakbas S; Slee M; Spitaleri D; Sanchez-Menoyo JL; Ampapa R; Hodgkinson S; Karabudak R; Vucic S; Butzkueven H, 2017, 'Effectiveness of fingolimod, dimethyl fumarate and teriflunomide in relapsing-remitting multiple sclerosis: a comparative longitudinal study', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, FRANCE, Paris, pp. 325 - 327, presented at 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), FRANCE, Paris, 25 October 2017 - 28 October 2017, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000413730202066&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Spelman T; Schulz M; Arora B; Chung E; Juneja P; Walker R; Verhaeghe S; Butzkueven H; Hodgkinson S; Lechner-Scott J; McCombe P; Slee M; Butler E; Barnett M; Skibina O; Vucic S; Macdonell R; Shuey N; Taylor B; Broadley S, 2017, 'Persistence to fingolimod compared with other disease modifying therapies in the Australian real-world setting using the MS base registry', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, FRANCE, Paris, pp. 631 - 631, presented at 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), FRANCE, Paris, 25 October 2017 - 28 October 2017, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000413730204050&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Jokubaitis V; Ai-Lan N; Kalincik T; van der Walt A; Lechner-Scott J; Barnett M; McCombe P; Vucic S; Hodgkinson S; Slee M; Skibina O; Shaw C; Butzkueven H, 2017, 'Pregnancy incidence, therapy exposure and post-partum relapse risk: a 12-year retrospective multicentre analysis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, AUSTRALIA, MS Res Australia, Sydney, pp. NP4 - NP4, presented at Progress in MS Research Conference, AUSTRALIA, MS Res Australia, Sydney, 11 October 2017 - 13 October 2017, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000414783200010&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Firtko A; Thomas P; Hodgkinson S, 2017, 'Effect of Post-Acute Nurse Led Stroke Clinic (PASC) on readmissions rates for TIA/Stroke', in INTERNATIONAL JOURNAL OF STROKE, SAGE PUBLICATIONS LTD, pp. 10 - 11, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000408220500026&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Jokubaitis VG; Li V; Kalincik T; Izquierdo G; Hodgkinson S; Alroughani R; Lechner-Scott J; Lugaresi A; Duquette P; Girard M; Barnett M; Grand'Maison F; Trojano M; Slee M; Giuliani G; Shaw C; Boz C; Haartsen J; Liew D; Butzkueven H, 2013, 'Does switching to fingolimod from natalizumab result in short-term relapse exacerbation?', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, DENMARK, Copenhagen, pp. 55 - 56, presented at 29th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis / 18th Annual Conference of Rehabilitation in MS, DENMARK, Copenhagen, 02 October 2013 - 05 October 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000328751400086&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Cordato DJ; Thomas PR; Darshan G; Sanjeev T; Worthington JM; McDougall AJ; Hodgkinson SJ; Ibrahim HY; Griffith NC; Cappelen-Smith C; Beran RG, 2010, 'Decreasing Presentations of Seizures to Emergency Departments in a Large Australian Population', in NEUROLOGY, LIPPINCOTT WILLIAMS & WILKINS, CANADA, Toronto, pp. A258 - A258, presented at 62nd Annual Meeting of the American-Academy-of-Neurology, CANADA, Toronto, 10 April 2010 - 17 April 2010, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000275274001259&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

LINDSEY JW; HODGKINSON S; MEHTA R; ENZMANN D; SANDERS M; STEINMAN L, 1993, 'PHASE-I STUDY OF REPEATED TREATMENT WITH CHIMERIC ANTI-CD4 MONOCLONAL-ANTIBODY IN MULTIPLE-SCLEROSIS', in NEUROLOGY, LIPPINCOTT-RAVEN PUBL, pp. A280 - A281, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1993KY35600489&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

LINDSEY JW; HODGKINSON S; MEHTA R; SIEGEL RC; MITCHELL DJ; LIM M; PIERCY C; TRAM T; DORFMAN L; ENZMANN D; STEINMAN L, 1992, 'PHASE-1 CLINICAL-TRIAL OF CHIMERIC MONOCLONAL ANTI-CD4 ANTIBODY IN MULTIPLE-SCLEROSIS', in NEUROLOGY, LITTLE BROWN CO, CA, SAN DIEGO, pp. 413 - 419, presented at 44th Annual Meeting of the American-Academy-of-Neurology, CA, SAN DIEGO, http://dx.doi.org/10.1212/WNL.44.3_Part_1.413

Conference Proceedings (Editor of)

Wang CC; Li J; Tran GT; Hodgkinson SJ; Hall BM; Mccaughan GW; Allen R; Bishop GA, (eds.), 2005, 'Immunology and Cell Biology', Blackwell Publishing Asia, Carlton, Victoria, Australia, presented at 23rd Annual Scientific Meeting of the Transplantation Society of Australia and NZ, Canberra, 11 May 2005 - 13 May 2005

Conference Presentations

Husin H; Wallace J; Malpas C; Sharmin S; Horakova D; Havrdova EK; Izquierdo G; Eichau S; Prat A; Girard M; Duquette P; Trojano M; Grammond P; Lugaresi A; Onofrj M; Ozakbas S; Butzkueven H; Sola P; Ferraro D; Alroughani R; Grand'Maison F; Terzi M; Lechner-Scott J; Boz C; Hupperts R; Shaygannejad V; Bergamaschi R; Pucci E; Van Pesch V; Hodgkinson S; McCombe P; Granella F; Slee M; Van Wijmeersch B; Karabudak R; Prevost J; Petersen T; Spitaleri D; Barnett M; Solaro C; Iuliano G; Verheul F; Ramo-Tello C; Turkoglu R; Fernandez Bolanos R; Butler E; Macdonell R; Soysal A; Betancur MM; Kalincik T, 2018, 'Determinants of MS re-activation after discontinuing therapies', presented at 34th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), GERMANY, Berlin, 10 October 2018 - 12 October 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000446861400464&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ledingham D; El-Wahsh S; Cappelen-Smith C; Hodgkinson S; McDougall A; Maley M; Cordato D, 2018, 'PARADOXICAL REACTION IN TUBERCULOUS MENINGITIS: A TERTIARY REFERRAL HOSPITAL RETROSPECTIVE EXPERIENCE OF CONCOMITANT IMMUNOSUPPRESSION THERAPY', presented at Annual Scientific Meeting of the Australian-and-New Zealand-Association-of-Neurologists (ANZAN), AUSTRALIA, Darwin, 29 May 2018 - 01 June 2018, http://dx.doi.org/10.1136/jnnp-2018-ANZAN.17

Conference Abstracts

Al-atiyah R; Verma N; Kawalia P; Tran G; Hodgkinson S; Hall B, 2024, 'Activation of human CD4+CD25+CD127lo Treg with alloantigen and rIL-2 induces IFNGR', in TRANSPLANTATION, LIPPINCOTT WILLIAMS & WILKINS, TURKEY, Istanbul, Vol. 108, presented at 30th International Congress of the Transplantation-Society (TTS), TURKEY, Istanbul, 22 September 2024 - 25 September 2024, http://dx.doi.org/10.1097/01.tp.0001065872.18320.b6

Rakesh P; Zahorowska B; Diep J; Cheung J; Wu P; Al-atiyah R; Suranyi M; Spicer T; Wong J; Tran G; Hodgkinson S; Hall B; Verma N, 2024, 'B cell phenotypes in peripheral blood of patients with renal allograft.', in TRANSPLANTATION, LIPPINCOTT WILLIAMS & WILKINS, TURKEY, Istanbul, Vol. 108, presented at 30th International Congress of the Transplantation-Society (TTS), TURKEY, Istanbul, 22 September 2024 - 25 September 2024, http://dx.doi.org/10.1097/01.tp.0001065376.80110.31

Verma N; Kawalia P; Al-atiyah R; Tran G; Rakesh P; Carter N; Hodgkinson S; Bruce H, 2024, 'Human CD4+CD25+CD127lo Treg can be activated in vitro with alloantigen and rIL-4 to induce receptor for interleukin 5 (IL-5Ra).', in TRANSPLANTATION, LIPPINCOTT WILLIAMS & WILKINS, TURKEY, Istanbul, Vol. 108, presented at 30th International Congress of the Transplantation-Society (TTS), TURKEY, Istanbul, 22 September 2024 - 25 September 2024, http://dx.doi.org/10.1097/01.tp.0001065108.83650.af

Rakesh P; Zahorowska B; Diep J; Cheung J; Wu P; Al-atiyah R; Suranyi M; Spicer T; Wong J; Tran G; Hodgkinson S; Hall B; Verma N, 2024, 'T regulatory cell phenotypes in renal transplant patients with long surviving graft, increased Th2-like Treg and reduced Th1-and Th17-like Treg.', in TRANSPLANTATION, LIPPINCOTT WILLIAMS & WILKINS, TURKEY, Istanbul, Vol. 108, presented at 30th International Congress of the Transplantation-Society (TTS), TURKEY, Istanbul, 22 September 2024 - 25 September 2024, http://dx.doi.org/10.1097/01.tp.0001065100.92615.5f

Rakesh P; Zahorowska B; Diep J; Cheung J; Wu P; Al-Atiyah R; Suranyi M; Spicer T; Wong J; Hodgkinson SJ; Hall BM; Verma ND, 2024, 'Examination of subsets of CD4+lymphocyte subpopulations in long-surviving renal transplant patients', in NEPHROLOGY DIALYSIS TRANSPLANTATION, OXFORD UNIV PRESS, SWEDEN, Stockholm, Vol. 39, presented at 61st Congress of European-Renal-Association (ERA), SWEDEN, Stockholm, 23 May 2024 - 26 May 2024, http://dx.doi.org/10.1093/ndt/gfae069.1666

Rakesh P; Zahorowska B; Diep J; Cheung J; Wu P; Al-Atiyah R; Suranyi M; Spicer T; Wong J; Hodgkinson SJ; Hall BM; Verma ND, 2024, 'Monitoring of peripheral blood B cell subsets in long-surviving renal transplant patients', in NEPHROLOGY DIALYSIS TRANSPLANTATION, OXFORD UNIV PRESS, SWEDEN, Stockholm, Vol. 39, presented at 61st Congress of European-Renal-Association (ERA), SWEDEN, Stockholm, 23 May 2024 - 26 May 2024, http://dx.doi.org/10.1093/ndt/gfae069.952

Harding-Forrester S; Roos I; Nguyen AL; Malpas CB; Diouf I; Moradi N; Sharmin S; Izquierdo G; Eichau S; Patti F; Horakova D; Kubala Havrdova E; Prat A; Girard M; Duquette P; Grand'Maison F; Onofrj M; Lugaresi A; Grammond P; Ozakbas, S; Amato MP; Gerlach O; Sola P; Ferraro D; Buzzard K; Skibina O; Lechner-Scott J; Alroughani R; Boz C; Van Pesch V; Cartechini E; Terzi M; Maimone D; Ramo-Tello C; Yamout B; Khoury SJ; La Spitaleri D; Sa MJ; Blanco Y; Granella F; Slee M; Butler E; Sidhom Y; Gouider R; Bergamaschi R; Karabudak R; Ampapa R; Sánchez-Menoyo JL; Prevost J; Castillo-Trivino T; McCombe PA; Macdonell R; Laureys G; Van Hijfte L; Oh J; Altintas A; De Gans K; Turkoglu R; Van Der Walt A; Butzkueven H; Vucic S; Barnett M; Cristiano E; Hodgkinson S; Iuliano G; Kappos L; Kuhle J; Shaygannejad V; Soysal A; Weinstock-Guttman B; Van Wijmeersch B; Kalincik T, 2023, 'Disability accrual in primary and secondary progressive multiple sclerosis', in Journal of Neurology Neurosurgery and Psychiatry, Vol. 94, pp. 707 - 717, http://dx.doi.org/10.1136/jnnp-2022-330726

Butzkueven H; Spelman T; Ozakbas S; Kalincik T; Boz C; Buzzard K; Skibina O; Alroughani R; Karabudak R; Van der Walt A; Lechner-Scott J; Hodgkinson S; Laureys G; Van Hijfte L; Terzi M; Butler E; Macdonell R; Patti F; Van Pesch V; Slee M; Barnett M; Grammond P; Prevost J; Grand-Maison F; Taylor B; Kermode A; Mccombe P; Duquette P; Prat A; Girard M; Eichau Madueno S; Izquierdo G; Soysal A; Sanchez-Menoyo JL; Sotoca J; Muros-Le Rouzic E; Dirks P, 2020, 'Real-world experience with ocrelizumab in the msbase registry', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, ELECTR NETWORK, Vol. 26, pp. 550 - 551, presented at 8th Joint ACTRIMS-ECTRIMS Meeting (MSVirtual), ELECTR NETWORK, 11 September 2020 - 13 September 2020

Pender MP; Hodgkinson SJ; Broadley S; Lindsey J; Ioannides ZA; Bagert B; Khanna R; Smith C; Gamelin L; Ye W; Willmer J; Bar-Or A, 2020, 'Phase i study of ata188, an off-the-shelf, allogeneic epstein-barr virus-targeted t-cell immunotherapy for progressive forms of multiple sclerosis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, ELECTR NETWORK, Vol. 26, pp. 228 - 228, presented at 8th Joint ACTRIMS-ECTRIMS Meeting (MSVirtual), ELECTR NETWORK, 11 September 2020 - 13 September 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000596547100451&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Jokubaitis V; Yeh W; Widyastuti P; Stankovich J; Gresle M; Havrdova EK; Horakova D; Vodehnalova K; Ozakbas S; Madueno SE; Duquette P; Kalincik T; Patti F; Boz C; Terzi M; Yamout B; Lechner-Scott J; Sola P; Skibina O; Barnett M; Onofrj M; Sa MJ; Mccombe P; Grammond P; Ampapa R; Grand'Maison F; Bergamaschi R; Spitaleri D; Van Pesch V; Cartechini E; Hodgkinson S; Soysal A; Saiz A; Uher T; Maimone D; Turkoglu R; Hupperts R; Amato MP; Granella F; Oreja-Guevara C; Altintas A; Macdonell R; Castillo-Trivino T; Butzkueven H; Alroughani R; Van der Walt A, 2020, 'Pregnancy in a modern day multiple sclerosis cohort: predictors of postpartum relapse and disability progression', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, ELECTR NETWORK, Vol. 26, pp. 652 - 653, presented at 8th Joint ACTRIMS-ECTRIMS Meeting (MSVirtual), ELECTR NETWORK, 11 September 2020 - 13 September 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000596547102220&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

O'Neill D; Sharma M; Gonzales B; Vandenheuval M; Tse B; Hodgkinson S, 2020, 'Switching from ocrelizumab to cladribine: real world data', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, ELECTR NETWORK, Vol. 26, pp. 67 - 68, presented at 8th Joint ACTRIMS-ECTRIMS Meeting (MSVirtual), ELECTR NETWORK, 11 September 2020 - 13 September 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000596547100128&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Verma N; O'Neill D; Al-Atiyah R; Sharma M; Tran G; Hall B; Hodgkinson S, 2020, 'The effect of cladribine upon naive and activated cd4(+) t regulatory cells in ms patients', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, ELECTR NETWORK, Vol. 26, pp. 314 - 314, presented at 8th Joint ACTRIMS-ECTRIMS Meeting (MSVirtual), ELECTR NETWORK, 11 September 2020 - 13 September 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000596547101180&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Maltby V; Lydon A; Monif M; Kilpatrick T; Butzkueven H; Taylor B; McCombe P; Hodgkinson S; Fabis-Pedrini M; Kermode A; Barnett M; Kalincik T; Lechner-Scott J, 2020, 'Cladribine: a multicentre LOng-term efficacy Biomarker Australian Study (CLOBAS)', in NEUROLOGY, LIPPINCOTT WILLIAMS & WILKINS, CANADA, Toronto, Vol. 94, presented at Annual Meeting of the American-Academy-of-Neurology, CANADA, Toronto, 25 April 2020 - 01 May 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000536058009096&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Sharmin S; Bovis F; Malpas C; Horakova D; Havrdova E; Ayuso GI; Eichau S; Trojano M; Prat A; Girard M; Duquette P; Onofrj M; Lugaresi A; Grand'Maison F; Grammond P; Sola P; Ferraro D; Terzi M; Hupperts RMM; Alroughani R; Boz C; Shaygannejad V; Van Pesch V; Kappos L; Lechner-Scott J; Bergamaschi R; Turkoglu R; Solaro C; Ramo-Tello C; Iuliano G; Granella F; Van Wijmeersch B; Spitaleri DLA; Fernandez Bolanos R; Slee M; McCombe P; Prevost J; Ampapa R; Ozakbas S; Luis Sanchez-Menoyo J; Soysal A; Vucic OS; Petersen T; Verheul F; Butler E; Hodgkinson S; Sidhom Y; Gouider R; Cristiano E; Olascoaga Urtaza FJ; Laura Saladino M; Barnett M; Deri N; Moore F; Rozsa C; Yamout B; Skibina O; Gray O; Campbell J; Sempere A; Singhal B; Fragoso Y; Shaw C; Kermode A; Petkovska-Boskova T; Taylor B; Simo M; Vella N; Shuey N; Alkhaboori J; Al-Harbi T; Macdonell R; Andres Dominguez J; Kister I; Csepany T; Vrech C; Kovacs K; Adella Sirbu C; Hughes S; Sormani MP; Butzkueven H; Kalincik T, 2020, 'Predicting Long-Term Sustained Disability Progression in Multiple Sclerosis', in NEUROLOGY, LIPPINCOTT WILLIAMS & WILKINS, CANADA, Toronto, Vol. 94, presented at Annual Meeting of the American-Academy-of-Neurology, CANADA, Toronto, 25 April 2020 - 01 May 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000536058004051&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Butzkueven H; Spelman T; Madueno SE; Grand'Maison F; Kalincik T; Hodgkinson S; Skibina O; Butler E, 2020, 'Real-world experience of oral cladribine use in the MSBase Registry', in NEUROLOGY, LIPPINCOTT WILLIAMS & WILKINS, CANADA, Toronto, Vol. 94, presented at Annual Meeting of the American-Academy-of-Neurology, CANADA, Toronto, 25 April 2020 - 01 May 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000536058006063&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

O'Neill D; Hodgkinson S, 2020, 'Short term efficacy and safety outcomes after switching from Anti-CD20 DMTs to Cladribine in a real-world setting', in NEUROLOGY, LIPPINCOTT WILLIAMS & WILKINS, CANADA, Toronto, Vol. 94, presented at Annual Meeting of the American-Academy-of-Neurology, CANADA, Toronto, 25 April 2020 - 01 May 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000536058009171&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

L-Scott J; Maltby V; Lydon A; Monif M; Kilpatrick T; Butzkueven H; Taylor B; McCombe P; Hodgkinson S; Fabis-Pedrini M; Kermode A; Barnett M; Kalincik T, 2019, 'Cladribine: a multicentre Long-term efficacy Biomarker Australian Study (CLOBAS)', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, SINGAPORE, Singapore, Vol. 26, pp. NP63 - NP63, presented at Conference of the Pan-Asian-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (PACTRIMS), SINGAPORE, Singapore, 13 November 2019 - 15 November 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000556862300075&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Hodgkinson S; Lizak N; Butler E; Lechner-Scott J; Slee M; McCombe P; Shaw C; Skibina O; Vucic S; Shuey N; Barnett M; Parratt J; Butzkueven H; Jack D; Fabris J; Kalincik T; Jokubaitis VG, 2019, 'Clinical experience with cladribine in patients with relapsing-remitting multiple sclerosis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, SINGAPORE, Singapore, Vol. 26, pp. NP64 - NP65, presented at Conference of the Pan-Asian-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (PACTRIMS), SINGAPORE, Singapore, 13 November 2019 - 15 November 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000556862300077&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Hodgkinson S; Butzkueven H; Spelman T; Patti F; Eichau S; Grand'Maison F; Kalincik T; Skibina O; Butler E, 2019, 'Real world experience with Cladribine (Mavenclad) in MSBase registry', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, SINGAPORE, Singapore, Vol. 26, pp. NP63 - NP64, presented at Conference of the Pan-Asian-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (PACTRIMS), SINGAPORE, Singapore, 13 November 2019 - 15 November 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000556862300076&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Verma ND; Chiu C; Lam A; Sharma M; Baker S; Limbu B; Robinson C; Tran G; Hall BM; Hodgkinson SJ, 2019, 'Multiple sclerosis associated with increased activated CD4+CD25+Foxp3+T regulatory cells but reduced Th17 associated regulatory cells', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, SWEDEN, Stockholm, Vol. 25, pp. 918 - 918, presented at 35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, SWEDEN, Stockholm, 11 September 2019 - 13 September 2019

Valente M; Cappelen-Smith C; Mcdougall A; Hodgkinson S; Thomas P; Cordato D, 2019, '"Code stroke" in the 24-hour time window from stroke onset: burden on hospital resources', in INTERNATIONAL JOURNAL OF STROKE, SAGE PUBLICATIONS LTD, Vol. 14, pp. 9 - 9, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000485243200034&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Bhaskar S; Saab J; Cappelen-Smith C; Cordato D; Cheung A; Manning N; Wenderoth J; Thomas P; Aouad P; Beran R; Hodgkinson S; McDougall A; Killingsworth M, 2019, 'Cryptogenic stroke is linked to cardioembolic aetiology: a histopathological study of thrombus retrieved after endovascular thrombectomy', in EUROPEAN JOURNAL OF NEUROLOGY, WILEY, NORWAY, Oslo, Vol. 26, pp. 20 - 20, presented at 5th Congress of the European-Academy-of-Neurology (EAN), NORWAY, Oslo, 29 June 2019 - 02 July 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000474481000035&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Bhaskar S; Saab J; Cappelen-Smith C; Cordato D; Cheung A; Manning N; Wenderoth J; Thomas P; Calic Z; Firtko A; Beran R; Hodgkinson S; McDougall A; Killingsworth M, 2019, 'Erythrocyte-rich clots are associated with cardioembolic aetiology, reduced number of manoeuvres, and improved clinical outcome in acute ischemic stroke patients', in EUROPEAN JOURNAL OF NEUROLOGY, WILEY, NORWAY, Oslo, Vol. 26, pp. 180 - 180, presented at 5th Congress of the European-Academy-of-Neurology (EAN), NORWAY, Oslo, 29 June 2019 - 02 July 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000474481000283&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lechner-Scott J; Maltby V; Lyndon A; Monif M; Kilpatrick T; Butzkueven H; Taylor B; McCombe P; Hodgkinson S; Fabis-Pedrini M; Kermode A; Barnett M; Kalincik T, 2019, 'CLADRIBINE: A MULTICENTRE LONG-TERM EFFICACY BIOMARKER AUSTRALIAN STUDY (CLOBAS)', in JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, BMJ PUBLISHING GROUP, AUSTRALIA, Sydney, Vol. 90, presented at Annual Scientific Meeting of the Australian-and-New Zealand-Association-of-Neurologists (ANZAN), AUSTRALIA, Sydney, 21 May 2019 - 24 May 2019, http://dx.doi.org/10.1136/jnnp-2019-anzan.119

Hall BM; Tran G; Verma ND; Robinson CM; Wilcox P; Hodgkinson SJ, 2019, 'Activation of naive CD4(+)CD25(+)FOXP3(+)Treg by specific autoantigen and Th2 cytokines IL-4 and IL-5 induces autoantigen specific Treg that inhibit EAE', in JOURNAL OF IMMUNOLOGY, AMER ASSOC IMMUNOLOGISTS, CA, San Diego, Vol. 202, presented at 103rd Annual Meeting of the American-Association-of-Immunologists, CA, San Diego, 09 May 2019 - 13 May 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000524982500434&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Back to profile page